7x Winner of the MMIT Patient Choice Award!

logo

Give us a call 855.726.8479 | 412.246.9858

Patient Portal Login
RYSTIGGO® (rozanolixizumab-noli)
www.rystiggo.com

RYSTIGGO (rozanolixizumab-noli) is indicated for the treatment of generalized myasthenia gravis (gMG) in adult patients who are anti-acetylcholine receptor (AChR) or anti-muscle-specific tyrosine kinase (MuSK) antibody positive.

Phone Icon

PANTHERx Rare Contact

  • 833-418-7760

Manufacturer Contact



24 Summit Park Drive
Pittsburgh, PA 15275 USA

Phone: 855.726.8479
(412.246.9858)

Fax: 855.246.3986
(412.787.9400)

Email: pharmacist@pantherxrare.com

Who We Serve
Patients
Manufacturers
Prescribers
Payers

About Us
Company Overview
Our History
Our Leadership
Press Releases
Resources Patients Medications Careers
Contact Us
Connect
Copyright © 2024 PANTHERx Rare, LLC. All rights reserved. PANTHERx RARE PHARMACY, “REINVENTING PHARMACY, REVOLUTIONIZING SPECIALTY, REDEFINING CARE”, and THE RARE DISEASE SP are registered service marks of PANTHERx Rare, LLC.
Twilio SMS Terms & Conditions | Privacy Policy | Legal Disclosure